Glaucoma Treatment Industry Research Report 2025

Summary

Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

According to APO Research, The global Glaucoma Treatment market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Glaucoma Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Glaucoma Treatment include Novartis, Allergan, Pfizer, Akorn, Teva, Bausch & Lomb, Otsuka Pharmaceutical, Santen and Lunan Pharma and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glaucoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Treatment.
The Glaucoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glaucoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Glaucoma Treatment Segment by Company

Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Glaucoma Treatment Segment by Product
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others
Glaucoma Treatment Segment by Application

Clinic
Pharmacy
Other
Glaucoma Treatment Segment by Application

Clinic
Pharmacy
Other
Glaucoma Treatment Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glaucoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glaucoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glaucoma Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Glaucoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Glaucoma Treatment by Product
2.2.1 Market Value Comparison by Product (2020 VS 2024 VS 2031)
2.2.2 Prostaglandin Analogs (PGAs)
2.2.3 Beta Blocker
2.2.4 Alpha Agonist
2.2.5 Others
2.3 Glaucoma Treatment by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Other
2.4 Assumptions and Limitations
3 Glaucoma Treatment Breakdown Data by Product
3.1 Global Glaucoma Treatment Historic Market Size by Product (2020-2025)
3.2 Global Glaucoma Treatment Forecasted Market Size by Product (2026-2031)
4 Glaucoma Treatment Breakdown Data by Application
4.1 Global Glaucoma Treatment Historic Market Size by Application (2020-2025)
4.2 Global Glaucoma Treatment Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Glaucoma Treatment Market Perspective (2020-2031)
5.2 Global Glaucoma Treatment Growth Trends by Region
5.2.1 Global Glaucoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Glaucoma Treatment Historic Market Size by Region (2020-2025)
5.2.3 Glaucoma Treatment Forecasted Market Size by Region (2026-2031)
5.3 Glaucoma Treatment Market Dynamics
5.3.1 Glaucoma Treatment Industry Trends
5.3.2 Glaucoma Treatment Market Drivers
5.3.3 Glaucoma Treatment Market Challenges
5.3.4 Glaucoma Treatment Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Glaucoma Treatment Players by Revenue
6.1.1 Global Top Glaucoma Treatment Players by Revenue (2020-2025)
6.1.2 Global Glaucoma Treatment Revenue Market Share by Players (2020-2025)
6.2 Global Glaucoma Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Glaucoma Treatment Head Office and Area Served
6.4 Global Glaucoma Treatment Players, Product Type & Application
6.5 Global Glaucoma Treatment Manufacturers Established Date
6.6 Global Glaucoma Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Glaucoma Treatment Market Size (2020-2031)
7.2 North America Glaucoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Glaucoma Treatment Market Size by Country (2020-2025)
7.4 North America Glaucoma Treatment Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Glaucoma Treatment Market Size (2020-2031)
8.2 Europe Glaucoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Glaucoma Treatment Market Size by Country (2020-2025)
8.4 Europe Glaucoma Treatment Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Glaucoma Treatment Market Size (2020-2031)
9.2 Asia-Pacific Glaucoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Glaucoma Treatment Market Size by Country (2020-2025)
9.4 Asia-Pacific Glaucoma Treatment Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Glaucoma Treatment Market Size (2020-2031)
10.2 South America Glaucoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Glaucoma Treatment Market Size by Country (2020-2025)
10.4 South America Glaucoma Treatment Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Glaucoma Treatment Market Size (2020-2031)
11.2 Middle East & Africa Glaucoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Glaucoma Treatment Market Size by Country (2020-2025)
11.4 Middle East & Africa Glaucoma Treatment Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Novartis
12.1.1 Novartis Company Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Revenue in Glaucoma Treatment Business (2020-2025)
12.1.4 Novartis Glaucoma Treatment Product Portfolio
12.1.5 Novartis Recent Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Revenue in Glaucoma Treatment Business (2020-2025)
12.2.4 Allergan Glaucoma Treatment Product Portfolio
12.2.5 Allergan Recent Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Revenue in Glaucoma Treatment Business (2020-2025)
12.3.4 Pfizer Glaucoma Treatment Product Portfolio
12.3.5 Pfizer Recent Developments
12.4 Akorn
12.4.1 Akorn Company Information
12.4.2 Akorn Business Overview
12.4.3 Akorn Revenue in Glaucoma Treatment Business (2020-2025)
12.4.4 Akorn Glaucoma Treatment Product Portfolio
12.4.5 Akorn Recent Developments
12.5 Teva
12.5.1 Teva Company Information
12.5.2 Teva Business Overview
12.5.3 Teva Revenue in Glaucoma Treatment Business (2020-2025)
12.5.4 Teva Glaucoma Treatment Product Portfolio
12.5.5 Teva Recent Developments
12.6 Bausch & Lomb
12.6.1 Bausch & Lomb Company Information
12.6.2 Bausch & Lomb Business Overview
12.6.3 Bausch & Lomb Revenue in Glaucoma Treatment Business (2020-2025)
12.6.4 Bausch & Lomb Glaucoma Treatment Product Portfolio
12.6.5 Bausch & Lomb Recent Developments
12.7 Otsuka Pharmaceutical
12.7.1 Otsuka Pharmaceutical Company Information
12.7.2 Otsuka Pharmaceutical Business Overview
12.7.3 Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2020-2025)
12.7.4 Otsuka Pharmaceutical Glaucoma Treatment Product Portfolio
12.7.5 Otsuka Pharmaceutical Recent Developments
12.8 Santen
12.8.1 Santen Company Information
12.8.2 Santen Business Overview
12.8.3 Santen Revenue in Glaucoma Treatment Business (2020-2025)
12.8.4 Santen Glaucoma Treatment Product Portfolio
12.8.5 Santen Recent Developments
12.9 Lunan Pharma
12.9.1 Lunan Pharma Company Information
12.9.2 Lunan Pharma Business Overview
12.9.3 Lunan Pharma Revenue in Glaucoma Treatment Business (2020-2025)
12.9.4 Lunan Pharma Glaucoma Treatment Product Portfolio
12.9.5 Lunan Pharma Recent Developments
12.10 Zizhu Pharma
12.10.1 Zizhu Pharma Company Information
12.10.2 Zizhu Pharma Business Overview
12.10.3 Zizhu Pharma Revenue in Glaucoma Treatment Business (2020-2025)
12.10.4 Zizhu Pharma Glaucoma Treatment Product Portfolio
12.10.5 Zizhu Pharma Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings